NCT06508697

Brief Summary

Fractional flow reserve (FFR)-guided PCI for chronic coronary syndromes (CCS) is reported to improve the outcomes compared with angiography-guided PCI. However, cardiac-events still occur in FFR-deferral patients in long-term follow-up. Coronary computed tomography angiography (CTA)-defined high-risk-plaque (HRP) is known to relate future cardiac events. The investigators hypothesized that CTA might identify plaque features linked to future cardiac events in deferral patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jan 2025Dec 2026

First Submitted

Initial submission to the registry

July 14, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

January 30, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

January 3, 2025

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

July 14, 2024

Last Update Submit

January 2, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Cardiac events in patient level

    a composite of cardiac death, non-fatal acute coronary syndrome (ACS), and ischemia-driven revascularization for patient-level analysis

    From 2018 to 2026

  • Cardiac events in lesion level

    lesion-level ACS and lesion-level ischemia-driven revascularization

    From 2018 to 2026

Study Arms (1)

Patients who underwent CTA within 90 days before ICA with FFR pressure

A consecutive series of patients who underwent Coronary computed tomography angiography (CTA) within 90 days before invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement were candidates for this study at Fujita Health University Hospital, Bantane Hospital, and Nagoya First Red Cross Hospital.

Diagnostic Test: invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement

Interventions

A consecutive series of patients who underwent Coronary computed tomography angiography (CTA) within 90 days before invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement were candidates for this study at Fujita Health University Hospital, Bantane Hospital, and Nagoya First Red Cross Hospital

Also known as: Coronary computed tomography angiography (CTA)
Patients who underwent CTA within 90 days before ICA with FFR pressure

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A consecutive series of 437 patients who underwent CTA within 90 days before ICA with FFR pressure measurement were candidates for this study at Fujita Health University Hospital, Bantane Hospital, and Nagoya First Red Cross Hospital

You may qualify if:

  • men and women aged ≥20 years,
  • patients having chronic coronary syndromes (CCS,
  • Coronary computed tomography angiography (CTA) was performed within 90 days before invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement.

You may not qualify if:

  • patients with a history of coronary bypass grafting (CABG) because CABG changed local coronary flow dynamics,
  • patients with left-main disease,
  • patients with fractional flow reserve (FFR) in stented vessels due to inability to estimate plaque morphology in the stented lesion by coronary computed tomography angiography.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujita Health University

Toyoake, Aichi-ken, 470-1192, Japan

RECRUITING

MeSH Terms

Conditions

Patient Preference

Condition Hierarchy (Ancestors)

Patient SatisfactionTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • YUKIO OZAKI, MD, PhD

    Fujita Health University, Aichi, Japan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

YUKIO OZAKI, MD, PhD

CONTACT

REINA OZAKI, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiology

Study Record Dates

First Submitted

July 14, 2024

First Posted

July 18, 2024

Study Start

January 30, 2025

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

January 3, 2025

Record last verified: 2024-07

Locations